Home >> Marketplace Directory >> HTG, Illumina agreement

HTG, Illumina agreement

image_pdfCreate PDF

January 2015—HTG Molecular Diagnostics has entered into an agreement with Illumina in which HTG will have the right to develop certain in vitro diagnostic test kits that use Illumina sequencing technology.

“We believe pairing the HTG Edge-Seq chemistry and automation platform with Illumina sequencing technology is a powerful combination for developing diagnostic panels that enable local molecular labs to adopt sequencing for routine clinical use,” TJ Johnson, HTG chief executive officer, said in a statement.

HTG Molecular Diagnostics, 877-289-2615

CAP TODAY
X